Pharmaceutical Industry Reports Endocrine Testing Market | Page 2

REPORT DESCRIPTION
Endocrine Testing Market – Overview
Major factor driving growth of the endocrine testing market is increasing prevalence of endocrinal disease which
requires first point diagnosis. Cushing syndrome is one of major endocrinal disorder. Cushing syndrome is result
of the excess exposure to hormone cortisol. Cortisol concentration may elevate due to longer treatment of chronic
asthma or rheumatoid arthritis and other causes. According to American Association of Neurological Surgeon
statistics, around 10-15 per million people are affected by Cushing syndrome every year. Prevalence of
postmenopausal osteoporosis is high, owing to low production of estradiol in women.
According to International Osteoporosis Foundation factsheet, around 30% of all postmenopausal women have
osteoporosis in the US and in Europe. Among them, 40% of women suffer from one or more fragility fractures in
their lifetime. Increasing ageing population is also expected to aid in growth of the endocrine testing market,
owing to high prevalence of endocrinal disease. According to population Prospect report by United Nations in
2017, an estimated 962 million people are aged 60 or above in the world, which accounted for 13% of the global
population. The number of older people in the world is projected to be 1.4 billion growing at annual rate of 3% by
2030.